← SunPower Inc.
| Annual Trend | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|
| Net loss | $5.1m | $6.0m | ($269.6m) | ($56.5m) | ($45.4m) | — | |
| Net loss from continuing operations, net of tax | — | ($28.0m) | ($96.2m) | ($54.4m) | ($44.3m) | — | |
| Net Income | — | ($29.5m) |
($269.6m)
-814.46%
|
($56.5m)
+79.06%
|
($45.4m)
+19.66%
|
($43.8m)
+3.39%
|
|
| Net Income From Continuing Operations | — | ($28.0m) | ($96.2m) | ($54.4m) | ($44.3m) | ($43.8m) | |
| Depreciation and amortization | — | $648k | $930k | $2.7m | $9.1m | $11.2m | |
| Amortization of debt issuance costs | — | — | — | $5.8m | $15.3m | — | |
| Depreciation Amortization Depletion | — | $648k | $930k | $2.7m | $9.1m | $11.2m | |
| Deferred income tax provision | — | — | — | $0 | $1.3m | $692k | |
| Deferred Tax | — | — | — | $0 | $1.3m | $692k | |
| Stock-based compensation expense | — | $433k | $3.4m | $3.1m | $10.5m | $11.6m | |
| Loss on impairments and disposals | — | — | — | $3.8m | $113k | — | |
| Asset Impairment Charge | — | — | $0 | $3.8m | $113k | $113k | |
| Change In Working Capital | — | ($7.6m) | ($10.5m) | ($6.6m) | ($3.1m) | ($11.9m) | |
| Accounts receivable | — | ($9.7m) | ($12.1m) | $3.3m | ($38.8m) | ($13.8m) | |
| Change In Receivables | — | ($9.7m) | ($12.1m) | ($18.1m) | ($30.3m) | ($13.8m) | |
| Changes In Account Receivables | — | ($9.7m) | ($12.1m) | $3.3m | ($38.8m) | ($13.8m) | |
| Inventories | — | ($5.0m) | $1.5m | $8.7m | $38.4m | $29.0m | |
| Change In Inventory | — | ($5.0m) | $1.5m | $8.7m | $38.4m | $29.0m | |
| Accounts payable | $2.6m | $2.3m | $2.3m | ($10.4m) | $15.3m | $6.6m | |
| Change In Payables And Accrued Expense | — | $2.1m | ($1.0m) | $3.7m | ($662k) | $6.6m | |
| Accrued expenses and other current liabilities | — | ($1.2m) | ($3.3m) | $14.1m | ($15.9m) | — | |
| Accrued interest | — | — | — | — | $213k | — | |
| Taxes accrued but unpaid related to net share settlement of equity awards | — | $6k | $0 | $10k | $1.2m | — | |
| Change In Accrued Expense | — | ($1.2m) | ($3.3m) | $14.1m | ($15.9m) | ($686k) | |
| Prepaid expenses and other current assets | — | $1.6m | ($4.2m) | ($170k) | ($4.9m) | — | |
| Change In Other Current Assets | — | ($1.1m) | $1.1m | $111k | ($664k) | ($693k) | |
| Change In Other Current Liabilities | — | — | ($598k) | ($849k) | ($1.5m) | ($1.5m) | |
| Net cash used in operating activities from continuing operations | ($2.0m) |
($1.4m)
+29.95%
|
($58.6m)
-3999.72%
|
($54.7m)
+6.74%
|
($15.3m)
+71.96%
|
($38.4m)
-150.25%
|
|
| Capital Expenditure | ($1.1m) | ($1.5m) | ($2.0m) | ($1.2m) | — | ($56.9m) | |
| Capital Expenditure Reported | — | ($1.5m) | ($1.9m) | ($1.2m) | $0 | ($56.9m) | |
| Cash paid for acquisitions; net of cash acquired | — | $4.8m | — | ($53.5m) | ($19.3m) | — | |
| Net cash used in investing activities from continuing operations | ($345.0m) | $3.3m | $6.2m | ($54.7m) | ($19.3m) | ($18.8m) | |
| Gain on troubled debt restructuring | — | ($3.2m) | $10.3m | ($22.3m) | — | — | |
| Accretion of debt in CS Solis | — | — | $6.6m | $3.9m | — | — | |
| Payment of debt issuance costs | — | — | — | — | ($200k) | — | |
| September 2024 Notes and related derivative liability, net of unamortized debt discount | — | — | — | — | $14.5m | — | |
| Debt issuance costs incurred in connection with the issuance of September 2025 Notes | — | — | — | — | $1.1m | — | |
| Cancellation of existing indebtedness in Exchange Agreement | — | — | — | $65.9m | — | — | |
| Warrants issued in debt issuance | — | — | — | $860k | — | — | |
| Issuance Of Debt | — | $42.5m | $35.4m | $107.7m | $27.0m | $38.8m | |
| Long Term Debt Issuance | — | $42.5m | $35.4m | $107.7m | $27.0m | $38.8m | |
| Long Term Debt Payments | — | ($10.0m) | ($9.8m) | ($851k) | ($4.4m) | ($5.7m) | |
| Net Issuance Payments Of Debt | — | $32.5m | $25.5m | $106.9m | $22.6m | $33.1m | |
| Net Long Term Debt Issuance | — | $32.5m | $25.5m | $106.9m | $22.6m | $33.1m | |
| Repayment Of Debt | — | ($10.0m) | ($9.8m) | ($851k) | ($4.4m) | ($5.7m) | |
| Loss on conversion of SAFE Agreements to shares of common stock with related party | — | — | — | $1.2m | — | — | |
| Proceeds from issuance of common stock | — | — | $5.0m | $6.7m | $6.7m | $13.7m | |
| Proceeds from exercise of common stock options | — | $128k | $57k | $532k | $480k | — | |
| Proceeds from exercise of warrant for common stock | — | — | — | — | $60k | — | |
| Issuance of common stock as partial consideration for acquisition of Sunder | — | — | — | — | $5.7m | $13.7m | |
| Issuance of common stock as partial purchase consideration for acquisition of Ambia | — | — | — | — | $16.5m | $13.7m | |
| Common stock | — | — | — | — | $1k | $13.7m | |
| Issuance of common stock in Exchange Agreement | — | — | — | $2.2m | — | $13.7m | |
| Conversion of SAFE Agreements to shares of common stock – related party | — | — | — | $5.0m | — | — | |
| Common Stock Issuance | — | $0 | $5.0m | $6.7m | $6.7m | $13.7m | |
| Issuance Of Capital Stock | — | $0 | $5.0m | $6.7m | $6.7m | $13.7m | |
| Taxes paid related to net share settlement of equity awards | — | $6k | $0 | $10k | ($727k) | — | |
| Other financing costs | — | — | — | $450k | — | — | |
| Net Other Financing Charges | — | ($1.4m) | $19.8m | $6.0m | $1.1m | $1.1m | |
| Net cash provided by financing activities from continuing operations | $347.3m |
$1.2m
-99.65%
|
$50.4m
+4016.33%
|
$120.1m
+138.18%
|
$30.9m
-74.27%
|
$53.4m
+72.69%
|
|
| Net increase (decrease) in cash, cash equivalents and restricted cash | — | $3.0m | ($1.9m) | $10.8m | ($3.8m) | — | |
| Cash, cash equivalents, and restricted cash at beginning of period | $278k | $73k | $8.3m | $17.2m | $13.5m | — | |
| Beginning Cash Position | — | $5.3m | $8.3m | $6.4m | $17.2m | $14.4m | |
| Effect of exchange rate changes on cash | — | $27k | $116k | $22k | $0 | $0 | |
| Additional Supplementary Disclosures | |||||||
| Additional Supplementary Disclosures | |||||||
| Loss from discontinued operations, net of income taxes | — | ($1.5m) | ($173.4m) | ($2.0m) | ($1.1m) | — | |
| Non-cash lease expense | — | $468k | $947k | $816k | $1.4m | — | |
| Provision for credit losses | — | $2.1m | $4.3m | $9.1m | $3.6m | — | |
| Change in fair value of SAFE Agreements with related party | — | — | — | ($616k) | $151k | — | |
| Change in fair value of deferred consideration | — | — | — | — | ($560k) | — | |
| Loss on issuance of derivative liability | — | — | — | $24.7m | — | — | |
| Change in fair value of derivative liabilities | — | — | — | ($34.0m) | ($11.5m) | — | |
| Change in fair value of warrant liabilities | ($9.4m) | ($5.5m) | ($29.3m) | ($2.9m) | $2.8m | — | |
| Change in fair value of forward purchase agreement liabilities | — | — | $3.9m | ($337k) | $471k | — | |
| Non-cash expense in connection with warrants issued for vendor services | — | — | — | $9.2m | — | — | |
| Non-cash income | — | — | — | — | ($628k) | — | |
| Non-cash interest expense | — | $4.8m | $4.9m | $1.8m | — | — | |
| Contract assets, current portion | — | — | ($1.7m) | $82k | $8.5m | — | |
| Other noncurrent assets | — | ($1.1m) | $1.1m | $111k | ($664k) | — | |
| Operating lease liabilities | — | ($617k) | ($598k) | ($849k) | ($1.5m) | — | |
| Warranty provision, noncurrent | — | $157k | $255k | $21k | ($378k) | — | |
| Contract liabilities | — | $1.3m | ($1.7m) | $82k | ($3.1m) | — | |
| Capitalization of internal-use-software costs | — | — | ($1.9m) | ($1.2m) | — | — | |
| Proceeds from issuance of convertible notes, net of issuance cost | — | $3.4m | $17.8m | $81.7m | $20.0m | — | |
| Proceeds from issuance of convertible notes to related parties | — | — | $3.5m | $26.0m | $7.0m | — | |
| Proceeds from issuance of SAFE agreements with related party | — | — | — | $6.0m | — | — | |
| Investor financing deposit – related party | — | — | — | — | $2.0m | — | |
| Principal repayment of notes payable | — | ($9.5m) | ($9.8m) | ($300k) | ($2.2m) | — | |
| Financing lease payments | — | — | — | ($551k) | ($2.3m) | — | |
| Cash paid during the year for interest | — | $162k | $2.1m | $77k | $7.7m | — | |
| Cash paid during the year for income taxes | — | $6k | $0 | $10k | $1.2m | — | |
| Issuance of Seller Note as partial purchase consideration for acquisition of Sunder(8) | — | — | — | — | $20.0m | — | |
| Deferred consideration recognized for acquisition of Sunder | — | — | — | — | $11.4m | — | |
| Deferred consideration recognized for acquisition of Ambia | — | — | — | — | $16.9m | — | |
| Additional paid-in capital | — | — | — | — | $14.7m | — | |
| Issuance of convertible notes in Exchange Agreement | — | — | — | $42.7m | — | — | |
| Operating lease right-of-use assets obtained in exchange for new operating lease liabilities | — | $245k | — | $116k | — | — | |
| Offering costs | — | — | — | $1.4m | — | — | |
| Carlyle Warrant modification – related party | — | — | $10.9m | $7.3m | — | — | |
| Cash Flow From Continuing Financing Activities | — | $31.2m | $50.4m | $120.1m | $30.9m | $53.4m | |
| Cash Flow From Continuing Investing Activities | — | $3.3m | $6.2m | ($54.7m) | ($19.3m) | ($18.8m) | |
| Change In Account Payable | — | $3.3m | $2.3m | ($10.4m) | $15.3m | $6.6m | |
| Change In Cash Supplemental As Reported | — | $3.0m | ($1.9m) | $10.8m | ($3.8m) | — | |
| Change In Other Working Capital | — | $4.5m | $4.7m | $103k | ($3.5m) | ($19.5m) | |
| Change In Payable | — | $3.3m | $2.3m | ($10.4m) | $15.3m | $6.6m | |
| Change In Prepaid Assets | — | $1.6m | ($4.2m) | ($170k) | ($4.9m) | ($11.4m) | |
| Changes In Cash | — | $3.0m | ($2.0m) | $10.8m | ($3.8m) | ($3.8m) | |
| End Cash Position | — | $8.3m | $6.4m | $17.2m | $13.5m | $10.6m | |
| Financing Cash Flow | — | $31.2m |
$50.4m
+61.67%
|
$120.1m
+138.18%
|
$30.9m
-74.27%
|
$53.4m
+72.69%
|
|
| Free Cash Flow | — | ($33.0m) | ($60.6m) | ($55.8m) | ($15.3m) | ($38.4m) | |
| Gain Loss On Investment Securities | — | $5.2m | ($21.2m) | ($3.4m) | ($8.2m) | ($20.0m) | |
| Investing Cash Flow | — | $3.3m | $6.2m | ($54.7m) | ($19.3m) | ($18.8m) | |
| Net Business Purchase And Sale | — | $4.8m | $0 | ($53.5m) | ($19.3m) | ($18.8m) | |
| Net Investment Purchase And Sale | — | $0 | $8.1m | $0 | — | — | |
| Net PPE Purchase And Sale | ($9k) | $0 | ($35k) | $0 | — | ($50.4m) | |
| Operating Gains Losses | — | $2.0m | ($10.9m) | ($3.4m) | ($8.2m) | ($20.0m) | |
| Other Non Cash Items | — | $5.3m | $50.3m | ($9.0m) | $15.7m | — | |
| Proceeds From Stock Option Exercised | — | $128k | $57k | $532k | $540k | $423k | |
| Provisionand Write Offof Assets | — | $2.1m | $4.3m | $9.1m | $3.6m | $2.5m | |
| Purchase Of Business | — | — | $0 | ($53.5m) | ($19.3m) | ($19.3m) | |
| Purchase Of PPE | ($9k) | $0 | ($35k) | $0 | — | ($56.9m) | |
| Sale Of Business | $0 | $4.8m | $0 | — | — | $121.7m | |
| Sale Of Investment | — | $0 | $8.1m | $0 | — | — | |
| Stock Based Compensation | — | $433k | $3.4m | $3.1m | $10.5m | $11.6m | |
| Unrealized Gain Loss On Investment Securities | $1.3m | $0 | — | — | — | — |